About this Journal Submit a Manuscript Table of Contents
Obstetrics and Gynecology International
Volume 2011 (2011), Article ID 609370, 7 pages
http://dx.doi.org/10.1155/2011/609370
Review Article

Polycystic Diseases in Visceral Organs

Department of Pharmacology, The University of Toledo, Health Science Campus, HEB 274, 3000 Arlington Avenue, MS 1015, Toledo, OH 43614, USA

Received 25 July 2011; Accepted 27 September 2011

Academic Editor: J. L. Simpson

Copyright © 2011 Shakila Abdul-Majeed and Surya M. Nauli. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. T. Christensen, S. F. Pedersen, P. Satir, I. R. Veland, and L. Schneider, “The primary cilium coordinates signaling pathways in cell cycle control and migration during development and tissue repair,” Current Topics in Developmental Biology, vol. 85, pp. 261–301, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. S. M. Nauli, H. S. Haymour, W. A. AbouAlaiwi, S. T. Lo, and A. M. Nauli, “Primary cilia are mechanosensory organelles in vestibular tissues,” in Mechanosensitivity and Mechanotransduction, chapter 14, Springer, Berlin, Germany, 2001.
  3. V. Singla and J. F. Reiter, “The primary cilium as the cell's antenna: signaling at a sensory organelle,” Science, vol. 313, no. 5787, pp. 629–633, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Abdul-Majeed and S. M. Nauli, “Calcium-mediated mechanisms of cystic expansion,” Biochimica et Biophysica Acta, vol. 1812, no. 10, pp. 1281–1290, 2011. View at Publisher · View at Google Scholar
  5. W. A. AbouAlaiwi, S. T. Lo, and S. M. Nauli, “Primary cilia: highly sophisticated biological sensors,” Sensors, vol. 9, no. 9, pp. 7003–7020, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Hildebrandt, T. Benzing, and N. Katsanis, “Ciliopathies,” The New England Journal of Medicine, vol. 364, no. 16, pp. 1533–1543, 2011. View at Publisher · View at Google Scholar
  7. R. J. Kolb and S. M. Nauli, “Ciliary dysfunction in polycystic kidney disease: an emerging model with polarizing potential,” Frontiers in Bioscience, vol. 13, no. 12, pp. 4451–4466, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Abdul-Majeed and S. M. Nauli, “Dopamine receptor type 5 in the primary cilia has dual chemo-and mechano-sensory roles,” Hypertension, vol. 58, no. 2, pp. 325–331, 2011. View at Publisher · View at Google Scholar
  9. S. Abdul-Majeed, B. C. Moloney, and S. M. Nauli, “Mechanisms regulating cilia growth and cilia function in endothelial cells,” Cellular and Molecular Life Sciences. In press. View at Publisher · View at Google Scholar
  10. W. A. Aboualaiwi, M. Takahashi, B. R. Mell et al., “Ciliary polycystin-2 is a mechanosensitive calcium channel involved in nitric oxide signaling cascades,” Circulation Research, vol. 104, no. 7, pp. 860–869, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. S. M. Nauli, Y. Kawanabe, J. J. Kaminski, W. J. Pearce, D. E. Ingber, and J. Zhou, “Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1,” Circulation, vol. 117, no. 9, pp. 1161–1171, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. S. M. Nauli, F. J. Alenghat, Y. Luo et al., “Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells,” Nature Genetics, vol. 33, no. 2, pp. 129–137, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. W. A. AbouAlaiwi, S. Ratnam, R. L. Booth, J. V. Shah, and S. M. Nauli, “Endothelial cells from humans and mice with polycystic kidney disease are characterized by polyploidy and chromosome segregation defects through survivin down-regulation,” Human Molecular Genetics, vol. 20, no. 2, Article ID ddq470, pp. 354–367, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Boehlke, F. Kotsis, V. Patel et al., “Primary cilia regulate mTORC1 activity and cell size through Lkb1,” Nature Cell Biology, vol. 12, no. 11, pp. 1115–1122, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Kim, N. A. Zaghloul, E. Bubenshchikova et al., “Nde1-mediated inhibition of ciliogenesis affects cell cycle re-entry,” Nature Cell Biology, vol. 13, no. 4, pp. 351–362, 2011. View at Publisher · View at Google Scholar
  16. M. A. Lancaster, J. Schroth, and J. G. Gleeson, “Subcellular spatial regulation of canonical Wnt signalling at the primary cilium,” Nature Cell Biology, vol. 13, no. 6, pp. 702–709, 2011. View at Publisher · View at Google Scholar
  17. F. Belibi, K. Ravichandran, I. Zafar, Z. He, and C. L. Edelstein, “mTORC1/2 and rapamycin in female Han:SPRD rats with polycystic kidney disease,” American Journal of Physiology, vol. 300, no. 1, pp. F236–F244, 2011. View at Publisher · View at Google Scholar
  18. S. Nagao, T. Yamaguchi, M. Kusaka et al., “Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease,” Kidney International, vol. 63, no. 2, pp. 427–437, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Yamaguchi, S. Nagao, D. P. Wallace et al., “Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys,” Kidney International, vol. 63, no. 6, pp. 1983–1994, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Yamaguchi, D. P. Wallace, B. S. Magenheimer, S. J. Hempson, J. J. Grantham, and J. P. Calvet, “Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype,” Journal of Biological Chemistry, vol. 279, no. 39, pp. 40419–40430, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. S. M. Nauli, S. Rossetti, R. J. Kolb et al., “Loss of polycystin-1 in human cyst-lining epithelia leads to ciliary dysfunction,” Journal of the American Society of Nephrology, vol. 17, no. 4, pp. 1015–1025, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Xu, S. Rossetti, L. Jiang et al., “Human ADPKD primary cyst epithelial cells with a novel, single codon deletion in the PKD1 gene exhibit defective ciliary polycystin localization and loss of flow-induced Ca2+ signaling,” American Journal of Physiology, vol. 292, no. 3, pp. F930–F945, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Xu, B. E. Shmukler, K. Nishimura et al., “Attenuated, flow-induced ATP release contributes to absence of flow-sensitive, purinergic Cai2+ signaling in human ADPKD cyst epithelial cells,” American Journal of Physiology, vol. 296, no. 6, pp. F1464–F1476, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. D. A. Cano, N. S. Murcia, G. J. Pazour, and M. Hebrok, “Orpk mouse model of polycystic kidney disease reveals essential role of primary cilia in pancreatic tissue organization,” Development, vol. 131, no. 14, pp. 3457–3467, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. D. A. Cano, S. Sekine, and M. Hebrok, “Primary cilia deletion in pancreatic epithelial cells results in cyst formation and pancreatitis,” Gastroenterology, vol. 131, no. 6, pp. 1856–1869, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. A. I. Masyuk, T. V. Masyuk, P. L. Splinter, B. Q. Huang, A. J. Stroope, and N. F. LaRusso, “Cholangiocyte cilia detect changes in luminal fluid flow and transmit them into intracellular Ca2+ and cAMP signaling,” Gastroenterology, vol. 131, no. 3, pp. 911–920, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. T. V. Masyuk, B. Q. Huang, C. J. Ward et al., “Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat,” Gastroenterology, vol. 125, no. 5, pp. 1303–1310, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Hughes, C. J. Ward, B. Peral et al., “The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains,” Nature Genetics, vol. 10, no. 2, pp. 151–160, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Mochizuki, G. Wu, T. Hayashi et al., “PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein,” Science, vol. 272, no. 5266, pp. 1339–1342, 1996. View at Scopus
  30. C. J. Ward, M. C. Hogan, S. Rossetti et al., “The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein,” Nature Genetics, vol. 30, no. 3, pp. 259–269, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. A. B. Chapman, K. Stepniakowski, and F. Rahbari-Oskoui, “Hypertension in autosomal dominant polycystic kidney disease,” Advances in Chronic Kidney Disease, vol. 17, no. 2, pp. 153–163, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. S. M. Nauli, X. Jin, and B. P. Hierck, “The mechanosensory role of primary cilia in vascular hypertension,” International Journal of Vascular Medicine, vol. 2011, Article ID 376281, 9 pages, 2011. View at Publisher · View at Google Scholar
  33. N. F. Berbari, A. K. O'Connor, C. J. Haycraft, and B. K. Yoder, “The primary cilium as a complex signaling center,” Current Biology, vol. 19, no. 13, pp. R526–R535, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. S. M. Nauli and J. Zhou, “Polycystins and mechanosensation in renal and nodal cilia,” BioEssays, vol. 26, no. 8, pp. 844–856, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Fischer, E. Legue, A. Doyen et al., “Defective planar cell polarity in polycystic kidney disease,” Nature Genetics, vol. 38, no. 1, pp. 21–23, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. V. Patel, L. Li, P. Cobo-stark et al., “Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia,” Human Molecular Genetics, vol. 17, no. 11, pp. 1578–1590, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. B. D. Cowley Jr., J. C. Rupp, M. J. Muessel, and V. H. Gattone II, “Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats,” American Journal of Kidney Diseases, vol. 29, no. 2, pp. 265–272, 1997. View at Scopus
  38. S. Silbiger and J. Neugarten, “Gender and human chronic renal disease,” Gender Medicine, vol. 5, no. 1, pp. S3–S10, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. K. D. Stringer, R. Komers, S. A. Osman, T. T. Oyama, J. N. Lendsley, and S. Anderson, “Gender hormones and the progression of experimental polycystic kidney disease,” Kidney International, vol. 68, no. 4, pp. 1729–1739, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. M. li Vecchi, P. Cianfrone, R. Damiano, and G. Fuiano, “Infertility in adults with polycystic kidney disease,” Nephrology Dialysis Transplantation, vol. 18, no. 1, pp. 190–191, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Shefi, J. Levron, A. Nadu, and G. Raviv, “Male infertility associated with adult dominant polycystic kidney disease: a case series,” Archives of Gynecology and Obstetrics, vol. 280, no. 3, pp. 457–460, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Torra, J. Sarquella, J. Calabia et al., “Prevalence of cysts in seminal tract and abnormal semen parameters in patients with autosomal dominant polycystic kidney disease,” Clinical Journal of the American Society of Nephrology, vol. 3, no. 3, pp. 790–793, 2008. View at Publisher · View at Google Scholar
  43. M. Manno, E. Marchesan, F. Tomei et al., “Polycystic kidney disease and infertility: case report and literature review,” Archivio Italiano di Urologia e Andrologia, vol. 77, no. 1, pp. 25–28, 2005. View at Scopus
  44. H. Okada, H. Fujioka, N. Tatsumi et al., “Assisted reproduction for infertile patients with 9+0 immotile spermatozoa associated with autosomal dominant polycystic kidney disease,” Human Reproduction, vol. 14, no. 1, pp. 110–113, 1999. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Milutinovic, P. J. Fialkow, L. Y. Agodoa, L. A. Phillips, and J. I. Bryant, “Fertility and pregnancy complications in women with autosomal dominant polycystic kidney disease,” Obstetrics and Gynecology, vol. 61, no. 5, pp. 566–570, 1983. View at Scopus
  46. N. Vora, R. Perrone, and D. W. Bianchi, “Reproductive issues for adults with autosomal dominant polycystic kidney disease,” American Journal of Kidney Diseases, vol. 51, no. 2, pp. 307–318, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. P. K. Heinonen, M. Vuento, M. Maunola, and I. Ala-Houhala, “Ovarian manifestations in women with autosomal dominant polycystic kidney disease,” American Journal of Kidney Diseases, vol. 40, no. 3, pp. 504–507, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. E. R. Stamm, R. R. Townsend, A. M. Johnson, K. Garg, M. Manco-Johnson, and P. A. Gabow, “Frequency of ovarian cysts in patients with autosomal dominant polycystic kidney disease,” American Journal of Kidney Diseases, vol. 34, no. 1, pp. 120–124, 1999. View at Scopus
  49. P. A. Gabow, A. M. Johnson, W. D. Kaehny, M. L. Manco-Johnson, I. T. Duley, and G. T. Everson, “Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease,” Hepatology, vol. 11, no. 6, pp. 1033–1037, 1990. View at Publisher · View at Google Scholar · View at Scopus
  50. P. C. Harris and V. E. Torres, “Polycystic kidney disease,” Annual Review of Medicine, vol. 60, pp. 321–337, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Sherstha, C. McKinley, P. Russ et al., “Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease,” Hepatology, vol. 26, no. 5, pp. 1282–1286, 1997. View at Scopus
  52. S. Davila, L. Furu, A. G. Gharavi et al., “Mutations in SEC63 cause autosomal dominant polycystic liver disease,” Nature Genetics, vol. 36, no. 6, pp. 575–577, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. E. Waanders, R. H. te Morsche, R. A. de Man, J. B. Jansen, and J. P. Drenth, “Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease,” Human Mutation, vol. 27, no. 8, p. 830, 2006. View at Scopus
  54. S. V. Fedeles, X. Tian, A. R. Gallagher et al., “A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation,” Nature Genetics, vol. 43, no. 7, pp. 639–647, 2011. View at Publisher · View at Google Scholar
  55. L. Müller, Y. Funato, H. Miki, and R. Zimmermann, “An interaction between human Sec63 and nucleoredoxin may provide the missing link between the SEC63 gene and polycystic liver disease,” FEBS Letters, vol. 585, no. 4, pp. 596–600, 2011. View at Publisher · View at Google Scholar
  56. Q. Qian, “Isolated polycystic liver disease,” Advances in Chronic Kidney Disease, vol. 17, no. 2, pp. 181–189, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. J. P. H. Drenth, J. A. Martina, R. V. D. Kerkhof, J. S. Bonifacino, and J. B. M. J. Jansen, “Polycystic liver disease is a disorder of cotranslational protein processing,” Trends in Molecular Medicine, vol. 11, no. 1, pp. 37–42, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. H. Gao, Y. Wang, T. Wegierski et al., “PRKCSH/80K-H, the protein mutated in polycystic liver disease, protects polycystin-2/TRPP2 against HERP-mediated degradation,” Human Molecular Genetics, vol. 19, no. 1, Article ID ddp463, pp. 16–24, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. A. R. Gallagher, E. L. Esquivel, T. S. Briere et al., “Biliary and pancreatic dysgenesis in mice harboring a mutation in Pkhd1,” American Journal of Pathology, vol. 172, no. 2, pp. 417–429, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. J. R. Woollard, R. Punyashtiti, S. Richardson et al., “A mouse model of autosomal recessive polycystic kidney disease with biliary duct and proximal tubule dilatation,” Kidney International, vol. 72, no. 3, pp. 328–336, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. C. E. Pierreux, A. V. Poll, C. R. Kemp et al., “The transcription factor hepatocyte nuclear factor-6 controls the development of pancreatic ducts in the mouse,” Gastroenterology, vol. 130, no. 2, pp. 532–541, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. C. G. Baptiste, M. C. Battista, A. Trottier, and J. P. Baillargeon, “Insulin and hyperandrogenism in women with polycystic ovary syndrome,” Journal of Steroid Biochemistry and Molecular Biology, vol. 122, no. 1–3, pp. 42–52, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. D. Dewailly, S. Hieronimus, P. Mirakian, and J. N. Hugues, “Polycystic ovary syndrome (PCOS),” Annales d'Endocrinologie, vol. 71, no. 1, pp. 8–13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. R. Homburg, “Androgen circle of polycystic ovary syndrome,” Human Reproduction, vol. 24, no. 7, pp. 1548–1555, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. A. H. Carey, K. L. Chan, F. Short, D. White, R. Williamson, and S. Franks, “Evidence for a single gene effect causing polycystic ovaries and male pattern baldness,” Clinical Endocrinology, vol. 38, no. 6, pp. 653–658, 1993. View at Scopus
  66. P. G. Crosignani and A. E. Nicolosi, “Polycystic ovarian disease: heritability and heterogeneity,” Human Reproduction Update, vol. 7, no. 1, pp. 3–7, 2001. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Franks, N. Gharani, D. Waterworth et al., “The genetic basis of polycystic ovary syndrome,” Human Reproduction, vol. 12, no. 12, pp. 2641–2648, 1997. View at Publisher · View at Google Scholar · View at Scopus
  68. B. Cloke and M. Christian, “The role of androgens and the androgen receptor in cycling endometrium,” Molecular and Cellular Endocrinology. In press. View at Publisher · View at Google Scholar
  69. L. E. Padua and B. A. Federici, “Development of mutants of the mosquitocidal bacterium Bacillus thuringiensis subspecies morrisoni (PG-14) toxic to lepidopterous or dipterous insects,” FEMS Microbiology Letters, vol. 66, no. 1–3, pp. 257–262, 1990. View at Scopus
  70. H. Shirwalkar, D. N. Modi, and A. Maitra, “Exposure of adult rats to estradiol valerate induces ovarian cyst with early senescence of follicles,” Molecular and Cellular Endocrinology, vol. 272, no. 1-2, pp. 22–37, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. H. Teede, A. Deeks, and L. Moran, “Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan,” BMC Medicine, vol. 8, p. 41, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. R. Pasquali, E. Stener-Victorin, B. O. Yildiz et al., “PCOS forum: research in polycystic ovary syndrome today and tomorrow,” Clinical Endocrinology, vol. 74, no. 4, pp. 424–433, 2011. View at Publisher · View at Google Scholar
  73. E. Deligeoroglou, C. Kouskouti, and P. Christopoulos, “The role of genes in the polycystic ovary syndrome: predisposition and mechanisms,” Gynecological Endocrinology, vol. 25, no. 9, pp. 603–609, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Simoni, C. B. Tempfer, B. Destenaves, and B. C. J. M. Fauser, “Functional genetic polymorphisms and female reproductive disorders: part I: polycystic ovary syndrome and ovarian response,” Human Reproduction Update, vol. 14, no. 5, pp. 459–484, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. S. Dasgupta and B. Reddy, “Present status of understanding on the genetic etiology of polycystic ovary syndrome,” Journal of Postgraduate Medicine, vol. 54, no. 2, pp. 115–125, 2008. View at Publisher · View at Google Scholar · View at Scopus
  76. M. R. Jones, A. Chua, Y. D. I. Chen et al., “Harnessing expression data to identify novel candidate genes in polycystic ovary syndrome,” PLoS ONE, vol. 6, no. 5, Article ID e20120, 2011. View at Publisher · View at Google Scholar
  77. J. R. Wood, V. L. Nelson, C. Ho et al., “The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis,” Journal of Biological Chemistry, vol. 278, no. 29, pp. 26380–26390, 2003. View at Publisher · View at Google Scholar · View at Scopus
  78. A. Badawy and A. Elnashar, “Treatment options for polycystic ovary syndrome,” International Journal of Women's Health, vol. 3, no. 1, pp. 25–35, 2011. View at Publisher · View at Google Scholar
  79. J. D. Lamb, E. B. Johnstone, J. A. Rousseau et al., “Physical activity in women with polycystic ovary syndrome: prevalence, predictors, and positive health associations,” American Journal of Obstetrics and Gynecology, vol. 204, no. 4, pp. 352.e1–352.e6, 2011. View at Publisher · View at Google Scholar
  80. M. Segasothy, M. Y. Norazlina, P. H. Ong, and M. Jamil, “Polycystic kidney disease associated with polycystic ovarian syndrome,” Nephron, vol. 62, no. 4, pp. 482–483, 1992. View at Scopus
  81. P. A. Gabow, “Autosomal dominant polycystic kidney disease—more than a renal disease,” American Journal of Kidney Diseases, vol. 16, no. 5, pp. 403–413, 1990. View at Scopus